Crystal structure of a ternary complex between human prostate-specific antigen, its substrate acyl intermediate and an activating antibody.

Human prostate-specific antigen (PSA or KLK3) is an important marker for the diagnosis and management of prostate cancer. This is an androgen-regulated glycoprotein of the kallikrein-related protease family secreted by prostatic epithelial cells. Its physiological function is to cleave semenogelins in the seminal coagulum and its enzymatic activity is strongly modulated by zinc ions. Here we present the first crystal structure of human PSA in complex with monoclonal antibody (mAb) 8G8F5 that enhances its enzymatic activity. The mAb recognizes an epitope composed of five discontinuous segments including residues from the kallikrein loop and stabilizes PSA in an "open and active conformation" that accelerates catalysis. We also present the crystal structure of PSA in complex with both the mAb 8G8F5 and a fluorogenic substrate Mu-KGISSQY-AFC, derived from semenogelin I. By exploiting the inhibition of PSA by zinc ions, we were able to obtain a substrate acyl intermediate covalently linked to the catalytic serine, at pH 7.3 but not at pH 5.5. Moreover, the inhibition of PSA activity by zinc was found to be modulated by pH variations but not by the antibody binding. The correlation of the different data with the physiological conditions under which PSA can cleave semenogelins is discussed.

[1]  M. Webber,et al.  Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  E. Diamandis,et al.  The kallikrein world: an update on the human tissue kallikreins , 2006, Biological chemistry.

[3]  J. Otlewski,et al.  Crystal structures of five bovine chymotrypsin complexes with P1 BPTI variants. , 2004, Journal of molecular biology.

[4]  S. Meldrum,et al.  Continuous measurement by radio-telemetry of vaginal pH during human coitus. , 1973, Journal of reproduction and fertility.

[5]  H. Lilja,et al.  Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen. , 1997, Cancer research.

[6]  B. Matthews,et al.  Structure of gamma-chymotrypsin in the range pH 2.0 to pH 10.5 suggests that gamma-chymotrypsin is a covalent acyl-enzyme adduct at low pH. , 1991, International journal of biological macromolecules.

[7]  R. Huber,et al.  Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site. , 2006, Journal of molecular biology.

[8]  R. Huber,et al.  The structure of a complex of recombinant hirudin and human alpha-thrombin. , 1990, Science.

[9]  Pauline M Rudd,et al.  Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. , 2003, Glycobiology.

[10]  M. Blaber,et al.  1.70 Å X‐ray structure of human apo kallikrein 1: Structural changes upon peptide inhibitor/substrate binding , 2005, Proteins.

[11]  G. Nemerow,et al.  Strategies in the crystallization of glycoproteins and protein complexes , 1992 .

[12]  E. Diamandis,et al.  Human Tissue Kallikrein 5 Is a Member of a Proteolytic Cascade Pathway Involved in Seminal Clot Liquefaction and Potentially in Prostate Cancer Progression* , 2006, Journal of Biological Chemistry.

[13]  R. Read,et al.  Structure of a serpin–protease complex shows inhibition by deformation , 2000, Nature.

[14]  Juan J Calvete,et al.  Crystal structure of a prostate kallikrein isolated from stallion seminal plasma: a homologue of human PSA. , 2002, Journal of molecular biology.

[15]  R. S. Mcgee,et al.  Human seminal vesicle-specific antigen is a substrate for prostate-specific antigen (or P-30). , 1988, Biology of reproduction.

[16]  H. Lilja,et al.  Enzymatic action of prostate‐specific antigen (PSA or hK3): Substrate specificity and regulation by Zn2+, a tight‐binding inhibitor , 2000, The Prostate.

[17]  U. Stenman,et al.  Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid. , 1995, Clinical chemistry.

[18]  G. Deléage,et al.  Selective recognition of enzymatically active prostate‐specific antigen (PSA) by anti‐PSA monoclonal antibodies , 2005, Journal of molecular recognition : JMR.

[19]  D. Corey,et al.  Substrate specificity of prostate-specific antigen (PSA). , 1998, Chemistry & biology.

[20]  P. Monget,et al.  Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3. , 2001, European journal of biochemistry.

[21]  G. Deléage,et al.  Anti-free prostate-specific antigen monoclonal antibody epitopes defined by mimotopes and molecular modeling. , 1999, Clinical chemistry.

[22]  J. Malm,et al.  Truncated semenogelin I binds zinc and is cleaved by prostate-specific antigen. , 2006, Journal of andrology.

[23]  J. Malm,et al.  Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen. , 2005, The Biochemical journal.

[24]  C. Lawson,et al.  Structural Investigation of Borrelia burgdorferi OspB, a BactericidalFab Target* , 2005, Journal of Biological Chemistry.

[25]  A. Vagin,et al.  MOLREP: an Automated Program for Molecular Replacement , 1997 .

[26]  Steven M. Thompson,et al.  Crystal Structure and Biochemical Characterization of Human Kallikrein 6 Reveals That a Trypsin-like Kallikrein Is Expressed in the Central Nervous System* , 2002, The Journal of Biological Chemistry.

[27]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[28]  D E McRee,et al.  XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density. , 1999, Journal of structural biology.

[29]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[30]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[31]  H. Lilja,et al.  Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. , 1990, European journal of biochemistry.